January 14, 2025

What Makes Skin Look Dry? Study Reveals

The perception of skin hydration relies on visual cues including lightness and color distribution.

Conexiant

January 14, 2025

Allergic Multimorbidity Linked to Mucosal Healing in UC

Patients with 3+ allergic conditions had 8x higher odds of achieving mucosal healing, highlighting potential shared immune pathways.

Conexiant

January 14, 2025

Novel Focal Point Technology Controls Laser Treatment Depth

"The focused ring beam spares an island of superficial tissue," researchers report in a new study demonstrating precise depth control in laser treatments while protecting the epidermis.

Conexiant

January 13, 2025

Melanoma Toolkit Enhances Primary Care Diagnostic Accuracy

"PCPs may serve as a valuable aid in skin cancer screening efforts."

Conexiant

January 13, 2025

Vitiligo Treatment: ASCS vs. NB-UVB

Autologous skin cell suspension therapy demonstrates effective and durable repigmentation for stable vitiligo, showing higher repigmentation rates compared to narrow-band ultraviolet B therapy alone.

Conexiant

January 13, 2025

Hidradenitis Suppurativa: Follicular Obstruction or Apocrine Glands?

New research challenges previous theories on the pathogenesis of hidradenitis suppurativa, suggesting a significant role of apocrine glands in the chronic skin condition. Read more in the Journal of Investigative Dermatology.

Conexiant

January 10, 2025

Higher H. pylori Prevalence Seen in Severe Psoriasis

Psoriasis patients show higher Helicobacter pylori infection rates, with potential implications for further research into disease associations.

Conexiant

January 10, 2025

EXOTIC Trial Tests Extended-Interval Omalizumab in Urticaria

Should omalizumab 6-week therapy prove non-inferior to 4-week therapy in maintaining disease control, 'this validation may enhance cost-effectiveness and spare patients of unnecessary injections and hospital visits.'

Conexiant

January 10, 2025

Remission Key to Successful Glucocorticoid Tapering

Discover how remission, hydroxychloroquine use, and gradual glucocorticoid tapering reduce flare risks in systemic lupus erythematosus.

Conexiant